Compare Natera Inc. Common Stock (NTRA) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs United Microelectronics Corp — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while United Microelectronics Corp trades at $20.58 (market cap $55.52B). The key difference: Natera Inc. Common Stock and United Microelectronics Corp are close in size by market cap, and United Microelectronics Corp pays a 1.79% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and United Microelectronics Corp for 42 Days on average.
| NTRA | UMC | |
|---|---|---|
Market Cap | $57.03B | $55.52B |
Volume | 1,131,157 | 8,712,351 |
Sector | Health | Technology |
52-Week High | $425.64 | $28.02 |
52-Week Low | $179.42 | $7.02 |
Typical Hold Time | 0 Days | 42 Days |
Enterprise Value | $56.18B | $52.61B |
Dividend Yield | — | 1.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
UMC trades at $22.39, down 0.71% on the day, with a bullish technical signal despite recent volatility. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.54 significantly exceeding the $0.16 forecast. Revenue is projected to grow to $250.7 billion in 2026, with a net income margin rebounding to 32.75%. Cash flow trends show improving operational performance, with net cash flow turning positive in 2025 at $5.66 billion.
The outlook is positive given strong earnings momentum and AI-driven demand, but risks include competitive pressures and sensitivity to semiconductor cycles. Analyst sentiment is mixed with a Hold consensus, though some upgrades to Strong Buy highlight growth potential. The stock's valuation multiples suggest room for appreciation if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
